Imaging Biometrics Ltd (IBAI) RNS Announcements

Add to Alert list
Date Time Source Announcement
01 Aug 2018 04:28 PM
RNS
Publication of a Prospectus

IQ-AI Ltd operates as an investment company. The principal activity of the group is the provision of convenient, cost-effective, and clinical treatments to patients in the field of medical imaging diagnostics, based on proven technologies. Its geographical segment includes Jersey and the United States of America and reportable segments are holding company expenses and medical software. The company derives a majority of revenue from the United States of America. It also supplies medical technology solutions and has a strong neuroimaging product portfolio.

IQ-AI share price listed in London at 87p in 1996.

UK 100

Latest directors dealings